Preferences help
enabled [disable] Abstract
Number of results
2004 | 51 | 4 | 1039-1046
Article title

Combined effects of radiotherapy and photodynamic therapy on an in vitro human prostate model.

Title variants
Languages of publication
Human prostate cancer cells were evaluated for growth after photodynamic therapy, radiotherapy, and combined treatment. Indocyanine green was tested as a photosensitizer and radiosensitizer. Two human cell lines were used: PC-3 derived from prostate carcinoma, and EPN derived from normal prostate tissue. The light source used for the photoactivation experiments was a diode laser peaked at 805 nm. The light dose incident on cells was 108 J/cm2. Ionizing radiation was produced by a linear accelerator, and the dose was 2, 4 and 6 Gy. Cytotoxicity was evaluated by measuring the colony forming ability of cells. Our results show that indocyanine green induces cell death by photoactivation, but it does not act as a radiosensitizer if used with ionizing radiation. The combined treatment of photodynamic therapy and radiotherapy produces an additive effect which does not depend on the sequence of the two treatments. Combined treatments could be more useful since they allow the reduction of the ionizing radiation dose to obtain the same effect as one obtainable by radiotherapy alone.
Physical description
  • Dipartimento di Biologia e Patologia Cellulare e Molecolare, University of Naples "Federico II", Naples, Italy
  • Istituto di Endocrinologia ed Oncologia Sperimentale-CNR, University of Naples "Federico II", Naples, Italy
  • Dipartimento di Biologia e Patologia Cellulare e Molecolare, University of Naples "Federico II", Naples, Italy
  • Dipartimento di Biologia e Patologia Cellulare e Molecolare, University of Naples "Federico II", Naples, Italy
  • Bäumler W, Abels C, Karrer S, Weiss T, Messmann H, Landthaler M, Szeimies RM. (1999) Photo-oxidative killing of human colonic cancer cells using indocyanine green and infrared light. Br J Cancer.; 80: 360-3.
  • Bellnier DA, Dougherty TJ. (1986) Haematoporphyrin derivative photosensitization and gamma-radiation damage interaction in Chinese hamster ovary fibroblasts. Int J Radiat Biol Relat Stud Phys Chem Med.; 50: 659-64.
  • Brancato R, Trabucchi G. (1998) Fluorescein and indocyanine green angiography in vascular chorioretinal diseases. Semin Ophthalmol.; 13: 189-98.
  • Carin T, Pardini RS. (1992) Oxygen dependence of hypericin-induced phototoxicity to EMT6 mouse mammary carcinoma cells. Photochem Photobiol.; 55: 831-7.
  • Chong L, Ozler P, de Queiroz JM, Liggett PE. (1993) Indocyanine green-enhanced diode laser treatment of melanoma in a rabbit model. Retina.; 13: 251-9.
  • Dearnaley DP. (2001) Radiotherapy and combined modality approaches in localised prostate cancer. Eur J Cancer.; 37 Suppl 7: 137-45.
  • Desmettre T, Devoisselle V, Soulie-Begu V, Mordon V. (1999) Fluorescence properties and metabolic features of indocyanine green. J Fr Ophtalmol.; 22: 1003-16.
  • El-Desoky A, Seifalian AM, Cope M, Delpy DT, Davidson BR. (1999) Experimental study of liver dysfunction evaluated by direct indocyanine green clearance using near infrared spectroscopy. Br J Surg.; 86: 1005-11.
  • Fagrell B. (1995) Advances in microcirculation network evaluation: an update. Int J Microcirc Clin Exp.; 15 Suppl 1: 34-40.
  • Fickweiler S, Szeimies RM, Bäumler W, Steinbach P, Karrer S, Goetz AE, Abels C, Hofstädter F, Landthaler M. (1997) Indocyanine green: intracellular uptake and phototherapeutic effects in vitro. J Photochem Photobiol B.; 38: 178-83.
  • Fox IJ, Wood EH. (1960) Indocyanine green: physical and physiologic properties. Mayo Clin Proc.; 35: 732-44.
  • Henschen S, Busse MW, Zisowsky S, Panning B. (1993) Determination of plasma volume and total blood volume using indocyanine green: a short review. J Med.; 24: 10-27.
  • Jori G. (1996) Tumour photosensitizers: approaches to enhance the selectivity and efficiency of photodynamic therapy. J Photochem Photobiol B.; 36: 87-93.
  • Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW. (1979) Establishment and characterization of a human prostatic cancer cell line (PC-3). Invest Urol.; 17: 16-23.
  • Luksiene Z, Kalvelyte A, Supino R. (1999) On the combination of photodynamic therapy with ionizing radiation. J Photochem Photobiol B.; 52: 35-42.
  • Owens SL. (1996) Indocyanine green angiography. Br J Ophthalmol.; 80: 263-6.
  • Ramakrishnan N, Clay ME, Friedman RL, Antunez AR, Oleinick NL. (1990) Post-treatment interactions of photodynamic and radiation-induced cytotoxic lesions. Photochem Photobiol.; 52: 555-9.
  • Reindl S, Penzkofer A, Gong SH, Landthaler M, Szeimies RM, Abels C, Bäumler W. (1997) Quantum yield of triplet formation for indocyanine green. J Photochem Photobiol A.; 105: 65-8.
  • Repetto L, Granetto C, Hall RR. (1998) Prostate cancer. Crit Rev Oncol Hematol.; 27: 145-6.
  • Schaffer M, Schaffer PM, Corti L, Gardiman M, Scotti G, Hofstetter A, Jori G, Duhmke E. (2002) Photofrin as a specific radiosensitizing agent for tumors: studies in comparison to other porphyrins, in an experimental in vivo model. J Photochem Photobiol B.; 66: 157-64.
  • Severson RK, Montie JE, Demers RY. (1995) Recent trends in incidence and treatment of prostate cancer among elderly men. J Natl Cancer Inst.; 87: 532-4.
  • Sinisi AA, Chieffi P, Pasquali D, Kisslinger A, Staibano S, Bellastella A, Tramontano D. (2002) EPN: a novel epithelial cell line derived from human prostate tissue. In Vitro Cell Dev Biol Anim.; 38: 165-72.
  • Szeimies RM, Hein R, Baumler W, Heine A, Landthaler MA. (1994) A possible new incoherent lamp for photodynamic treatment of superficial skin lesions. Acta Derm Venereol (Stockh).; 74: 117-9.
  • Szostak MJ, Kyprianou N. (2000) Radiation-induced apoptosis: predictive and therapeutic significance in radiotherapy of prostate. Oncol Rep.; 7: 699-706.
  • Wietasch GJ, Mielck F, Scholz M, von Spiegel V, Sthephan V, Hoeft A. (2000) Bedside assessment of cerebral blood flow by double-indicator dilution technique. Anesthesiology.; 92: 367-75.
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.